Percutaneous Heart Valves Tomorrow, Surgical Improvements Today
This article was originally published in Start Up
According to a report just issued by Health Research International, "Opportunities in Heart Valve Disease Management: Europe, Japan, and Rest of World," sales of heart valves-both the percutaneous and surgical products-will increase almost 9% annually, to $900 million in 2010 in ex-US markets. Driving growth in the market will be a growing tendency to perform valve surgeries concomitantly with coronary artery bypass graft procedures, demographics (an increase in the aged), and emerging markets in developing countries.
You may also be interested in...
Short summaries of notable clinical and product news items in the device industry.
Full-scale commercialization of percutaneous heart valve technology is still years away, but Evalve's new approach to mitral repair is closest to the clinic.
Health Research International has just issued a report, "US Opportunities in Heart Valve Disease Management." According to the report, the market for valve replacement and repair products will grow from more than $500 million in 2004 to some $900 million in 2010, with the greatest growth occurring in percutaneous valve products.